Neurosteroids, stress and depression: potential therapeutic opportunities.
about
Neuroinflammation and psychiatric illnessTranslocator protein-mediated pharmacology of cholesterol transport and steroidogenesisGABAA receptor-acting neurosteroids: a role in the development and regulation of the stress responseInhibition of CaV3.2 T-type calcium channels in peripheral sensory neurons contributes to analgesic properties of epipregnanolone.Persistent Effects of Developmental Exposure to 17α-Ethinylestradiol on the Zebrafish (Danio rerio) Brain Transcriptome and BehaviorProtocadherin 19 (PCDH19) interacts with paraspeckle protein NONO to co-regulate gene expression with estrogen receptor alpha (ERα).TSPO activation modulates the effects of high pressure in a rat ex vivo glaucoma model.Tomato juice intake increases resting energy expenditure and improves hypertriglyceridemia in middle-aged women: an open-label, single-arm study.A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depressionUnderstanding the pharmacogenetics of selective serotonin reuptake inhibitors.Neurosteroid biosynthesis downregulation and changes in GABAA receptor subunit composition: A biomarker axis in stress-induced cognitive and emotional impairment.Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease.Pregnenolone sulfate as a modulator of synaptic plasticity.During postnatal development endogenous neurosteroids influence GABA-ergic neurotransmission of mouse cortical neurons.An altered peripheral IL6 response in major depressive disorderAnxiolytic-like effect of ethanolic extract of Argemone mexicana and its alkaloids in Wistar rats.Dysfunctional astrocytic and synaptic regulation of hypothalamic glutamatergic transmission in a mouse model of early-life adversity: relevance to neurosteroids and programming of the stress response.Neurosteroid Agonist at GABAA receptor induces persistent neuroplasticity in VTA dopamine neurons.Acute and chronic effects of ethanol on learning-related synaptic plasticity.Lipids, lipoprotein distribution and depressive symptoms: the Multi-Ethnic Study of Atherosclerosis.Pregnanolone Glutamate, a Novel Use-Dependent NMDA Receptor Inhibitor, Exerts Antidepressant-Like Properties in Animal Models.The relationship between statins and depression: a review of the literature.Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management.Neurosteroid analogues. 18. Structure-activity studies of ent-steroid potentiators of γ-aminobutyric acid type A receptors and comparison of their activities with those of alphaxalone and allopregnanolone.Alendronate treatment induces IL-1B expression and apoptosis in glioblastoma cell line.Neurotoxicity of Ammonia.A users guide to HPA axis research.Forebrain glutamatergic, but not GABAergic, neurons mediate anxiogenic effects of the glucocorticoid receptor.Developmentally regulated neurosteroid synthesis enhances GABAergic neurotransmission in mouse thalamocortical neurones.The development of benzo- and naphtho-fused quinoline-2,4-dicarboxylic acids as vesicular glutamate transporter (VGLUT) inhibitors reveals a possible role for neuroactive steroids.A clickable neurosteroid photolabel reveals selective Golgi compartmentalization with preferential impact on proximal inhibitionAmmonia inhibits long-term potentiation via neurosteroid synthesis in hippocampal pyramidal neurons.Mapping Two Neurosteroid Modulatory Sites in the Prototypic Pentameric Ligand Gated Ion Channel GLIC.Dynamic Adaptation in Neurosteroid Networks in Response to Alcohol.Antidepressant-Like and Anxiolytic-Like Effects of ZBD-2, a Novel Ligand for the Translocator Protein (18 kDa).Effect of psychotropic drug treatment on sterol metabolism.Neurosteroids in Schizophrenia: Pathogenic and Therapeutic Implications.Androgen Regulation of the Mesocorticolimbic System and Executive Function.Brexanolone: an allosteric modulator of GABA-A receptors in the rapid treatment of postpartum depressionTranslocator protein ligand, YL-IPA08, attenuates lipopolysaccharide-induced depression-like behavior by promoting neural regeneration
P2860
Q21245244-C20AB5A5-3B6D-4555-92DE-5B2017D58314Q28083751-0021943B-6923-492B-ADC7-F15182FCD42AQ28241963-A99A0B5F-3078-485B-B7FC-0E030C10E6B7Q30371210-BC0C20FE-977D-412C-9665-225AFFB3C3DCQ30846132-839E8009-78B5-4338-83C1-209A0ABAB8DAQ33706367-4C265D89-AA67-4C98-B348-A60E352644C6Q33807216-39F858ED-D93D-4DD6-AE0E-5AB6AE7F067CQ34043781-2FA462F7-EBE9-487B-AA9D-E62DA96638F5Q34357016-2583E685-3C53-4AF5-8EF6-9E81D34ADDD9Q34424865-58342E02-1262-4D35-AB3E-A9DEFC0179A7Q34556039-859CB14D-9B40-48FF-93DC-146D065F9763Q35650967-4F8A4859-EFAA-4215-9067-3A8F277F98BBQ36224315-D9C2F2CD-F30F-4612-9177-CFFF7F6E5C46Q36610262-860BF0B2-3C11-4EF9-882D-7A2BDCBF7FEDQ36669690-34EE9838-E4E9-4E1B-91EC-5CB131DE9D10Q37141068-79C85A43-7A35-4112-B4C0-F81CFF88BBC4Q37381812-BF172A3D-0D0A-43AD-81CB-1902A16B2141Q37491621-E42754F5-9C9F-4816-90E5-98F4E48AA616Q37581600-6F089D26-909C-4A74-87D3-39EF1E70C979Q37622666-D39B6BA0-B7DA-46EE-A8B1-2E741A55BE67Q37718994-643B3A0E-9A23-4B79-A137-449415EA10CEQ38114474-50CE148C-D9E2-4CEF-9FC2-B64FF4E8EE46Q38179262-DC59FEE0-9116-4235-B3D5-DAEA643C7EEBQ38259021-70BE4D40-8A02-4536-B133-BBEA3136F746Q38699184-A52EAF96-80D8-4F69-9264-76B87DCA75C2Q38910515-7B47BBA8-23A1-49C4-8C1B-EFDA8B7DE2F0Q39015880-82ECE7A5-3FB7-4FC4-89F2-EAE23F0B7A93Q40728572-D1CD7495-9DDD-42A7-A8F0-C71DEC979D13Q41628434-827DDA6B-039F-4A34-82F8-B9CD9BB88D83Q42000948-7990AB25-FDFE-4F80-AEC2-1E0FEA44F77EQ42072055-123C08D6-E9C4-4BFC-801F-2B5A9632EFC2Q43156054-D2F4A3C6-5550-4572-9E4A-5C8457DB10FDQ47215360-2AAE7437-0DA6-46B7-AB83-908035A34897Q47306333-D744BAC5-1022-4AD7-9D2B-40837731B0C8Q48044683-A9749258-34D5-4DBE-92AF-7C5281AACC8BQ48307633-DD3174E0-53C7-4EA5-A2CA-A7ED98262139Q52641631-1C2836DB-DE53-4C29-8ED2-54D05927C81EQ55344917-0A4EE736-E016-4A32-ADE9-639799AEA317Q57820106-0B9F3F8C-A55A-41D9-BB8F-7D518A41B9A3Q58702659-A15B39D8-9688-4418-9F07-E2D91313BEDD
P2860
Neurosteroids, stress and depression: potential therapeutic opportunities.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Neurosteroids, stress and depression: potential therapeutic opportunities.
@ast
Neurosteroids, stress and depression: potential therapeutic opportunities.
@en
type
label
Neurosteroids, stress and depression: potential therapeutic opportunities.
@ast
Neurosteroids, stress and depression: potential therapeutic opportunities.
@en
prefLabel
Neurosteroids, stress and depression: potential therapeutic opportunities.
@ast
Neurosteroids, stress and depression: potential therapeutic opportunities.
@en
P2093
P2860
P1476
Neurosteroids, stress and depression: potential therapeutic opportunities
@en
P2093
Charles F Zorumski
Douglas F Covey
Steven M Paul
Yukitoshi Izumi
P2860
P304
P356
10.1016/J.NEUBIOREV.2012.10.005
P577
2012-10-17T00:00:00Z